Abstract:
Food products for nutrition of infants which contain no more than subirritant amounts of free long-chain (C16-C22) fatty acids and triglycerides thereof are disclosed. Providing esters, such as ethyl esters, of such fatty acids in infant food products essentially eliminates the tendency of the fatty acid to damage the infant intestinal epithelium, but permits absorption and processing of the fatty acid moiety.
Abstract:
The present invention relates to a newly discovered Bacillus thuringiensis strains and toxins which exhibit nematocidal activity in agricultural and horticultural settings. These strains and toxins can be used as a biocontrol agent in the treatment and prevention of nematode infection in plants, and particularly in commercially important crop plants.
Abstract:
The invention relates to a chiral selector useful in separating underivatized enantiomers of non-steroidal anti-inflammatory agents, particularly naproxen and other arylacetic acid compounds, and relates to a process for achieving such separation utilizing the chiral selector, which is also useful in achieving the enantiomeric separation of amines, alcohol derivatives, epoxides and sulfoxides. The invention is also directed to an apparatus which comprises the chiral selectors.
Abstract:
The present invention relates to novel substantially pure amorphous metals and the sonochemical synthesis thereof comprising irradiating volatile organometallic compounds with high intensity ultrasound. The present invention is further directed to the use of amorphous metals as reactive catalysts for various processes such as the Fischer-Tropsch hydrogenation of carbon monoxide and for the hydrogenolysis and dehydrogenation of saturated hydrocarbons. The present invention further relates to the use of these amorphous metals as soft ferromagnetic materials.
Abstract:
Phenoxazines, unsubstituted or N-substituted as defined herein, can potentiate the antitumor effectiveness of chemotherapeutic agents, particularly in multiple drug resistant (MDR) cells.
Abstract:
C60 and C70 carbon atom compounds are prepared by evaporating graphite in an inert quenching gas. The vapor of carbon is collected and is selectively extracted with an organic non-polar solvent.
Abstract:
The present invention is directed to a gene encoding an envelope glycoprotein of equine herpesvirus type 1 (EHV-1), the glycoprotein D (gD) gene, its gene product and antibodies directed against gD polypeptides. The envelope glycoproteins of herpesvirus are major targets of the immune response to herpesviral infection. Hence, an important aspect of this invention is directed towards a vaccine against EHV-1 and treatment of EHV-1 infection by anti-EHV-gD antibodies or antisera.
Abstract:
This invention relates to a compound useful for the treatment of tumors having formula (I), wherein R8, R6 and R10 are independently hydrogen, lower alkyl, aryl, lower alkanoyl, formyl, halogen, nitro, NR2R3, OR1, or SR1, methoxy, hydroxy, cyano CO2H, SO2NR1R2, or CONR1R2; R1, R2 and R3 are independently hydrogen, lower alkyl, aryl lower alkyl, aryl, formyl or lower alkanoyl; R9, R11, R10 and R7 are independently hydrogen, or lower alkyl or R9 and R11 taken together with the carbon atoms to which they are attached form a phenyl group or R9 and R10 taken together with the carbon atoms to which they are attached form a phenyl group or R7 and R10 taken together with the carbon atoms to which they are attached from a phenyl group; A is (CR4R5)n3, lower cycloalkyl or aryl or a chemical bond; each R4 and R5 are independently hydrogen or lower alkyl; R12 and R13 are independently hydrogen, or lower alkyl which is unsubstituted or substituted with hydroxy, mercapto, lower alkoxy, lower alkylcarbonyloxy, carboxy, or carbloweralkoxy or R12 and R13 taken together with the nitrogen to which they are attached form a 3-6-membered heterocyclic ring; D is a chemical bond or taken together with NR12 form a 5 or 6-membered heterocyclic ring; n1 and n2 are independently 0, 1 or 2; and n3 is 0, 1, 2, 3, 4 or 5.
Abstract translation:本发明涉及可用于治疗具有式(I)的肿瘤的化合物,其中R 8,R 6和R 10独立地是氢,低级烷基,芳基,低级烷酰基,甲酰基,卤素,硝基,NR 2 R 3,OR 1或SR 1,甲氧基 ,羟基,氰基CO 2 H,SO 2 NR 1 R 2或CONR 1 R 2; R1,R2和R3独立地是氢,低级烷基,芳基低级烷基,芳基,甲酰基或低级烷酰基; R9,R11,R10和R7独立地为氢,或低级烷基或R9和R11与它们所连接的碳原子一起形成苯基或R 9和R 10与它们所连接的碳原子一起形成 苯基或R 7和R 10与它们所连接的碳原子一起与苯基一起; A是(CR4R5)n3,低级环烷基或芳基或化学键; 每个R 4和R 5独立地是氢或低级烷基; R 12和R 13独立地为氢,或未被取代或被羟基,巯基,低级烷氧基,低级烷基羰基氧基,羧基或碳氟烷基氧基取代的低级烷基,或者与它们所连接的氮一起形成的R 12和R 13一起形成3-6元环, 元环杂环; D是化学键或与NR12一起形成5或6元杂环; n1和n2独立地为0,1或2; n3为0,1,2,3,4或5。
Abstract:
The present invention relates to contrast enhancing agents, conjugates thereof, pharmaceutical compositions thereof, and methods for diagnostic analysis, particularly NMR image analysis using these agents. The contrast enhancing agents are chelates of paramagnetic, ferromagnetic or diamagnetic metal ion(s) complexed with new lipophilic complexing acids related to polyaminopolycarboxylic acids.
Abstract:
Methods of coating nanoparticles (30) with one or more layers of various types of materials such as metals (30b), polymers (30c) and halides (30d), and nanoparticles formed by those methods. A first embodiment of the invention is a method of forming silver halide (12b) coated dielectric nanoparticles (12a), and a second embodiment is a method of forming metal (14b) coated dielectric nanoparticles (14a). A first nanoparticle according to this invention comprises a dielectric nano-core and a silver halide coating; and a second nanoparticle comprises a dielectric nano-core, a metal shell over that core and a silver halide (14c) coating over the metal shell. A further nanoparticle of this invention comprises a dielectric nano-core (16a), a silver halide shell (16b) over the core and a metal shell (16c) over the silver halide; and a still further nanoparticle comprises a dielectric core (20a), a first shell of a first metal (20b) and a second shell (20c) of a second metal.